Indaptus Therapeutics (NASDAQ:INDP) Releases Earnings Results, Beats Estimates By $0.07 EPS
Indaptus Therapeutics (NASDAQ:INDP – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.47) EPS for the quarter, topping analysts’ consensus estimates of ($0.54) by $0.07, Zacks reports. Indaptus Therapeutics Stock Performance Shares of NASDAQ:INDP traded up $0.01 during mid-day trading on Wednesday, reaching $1.68. 3,399 shares of the company’s stock […]
More Stories
Oppenheimer & Co. Inc. Has $855,000 Position in SPDR Bloomberg High Yield Bond ETF (NYSEARCA:JNK)
Oppenheimer & Co. Inc. cut its stake in shares of SPDR Bloomberg High Yield Bond ETF (NYSEARCA:JNK – Free Report)...
BlackRock Capital Allocation Term Trust (NYSE:BCAT) Shares Bought by Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. lifted its stake in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by...
Oppenheimer & Co. Inc. Has $1.04 Million Stake in Sprouts Farmers Market, Inc. (NASDAQ:SFM)
Oppenheimer & Co. Inc. trimmed its holdings in shares of Sprouts Farmers Market, Inc. (NASDAQ:SFM – Free Report) by 7.0%...
Oppenheimer & Co. Inc. Buys Shares of 10,052 SPDR S&P Homebuilders ETF (NYSEARCA:XHB)
Oppenheimer & Co. Inc. purchased a new position in SPDR S&P Homebuilders ETF (NYSEARCA:XHB – Free Report) during the first...
Oppenheimer & Co. Inc. Trims Stock Holdings in Invesco Water Resources ETF (NASDAQ:PHO)
Oppenheimer & Co. Inc. reduced its position in Invesco Water Resources ETF (NASDAQ:PHO – Free Report) by 2.2% in the...
KANZHUN LIMITED Sponsored ADR (NASDAQ:BZ) Position Lifted by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. raised its stake in KANZHUN LIMITED Sponsored ADR (NASDAQ:BZ – Free Report) by 42.2% in the...